Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
Kappa and Lambda Light Chains - The Myeloma Crowd
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
The Heavy Chain Diseases: Clinical and Pathologic Features
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD